Aagami are glad to announce that their Japanese client has given a new assignment, to seek partnerships for one more asset in their pipeline. Aagami a...
Published : 22 Nov 2022
Read MoreBio2Device Group (B2DG), CA have organized an event where Aagami CEO Dinesh Jain will be speaking on "How To Do Cross Border Partnering in Lifescience...
Published : 14 Nov 2022
Read MoreAagami VP Godwyn Francis participated in “Global Bio & Pharma Plaza 2022” This partnering event was held from Oct 12th to 13th, 2022 in S...
Published : 28 Oct 2022
Read MoreAagami successfully completed Bio-Japan 2022 (October 11-14) with more than 25 fruitful meetings. Akshay Bavaria, BD Manager led the digital part...
Published : 22 Oct 2022
Read MoreNFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addict...
Published : 10 Oct 2022
Read MoreFrench Biotech client awarded yet another contract extension to Aagami. Client is a publicly listed company developing a drug for smoking cessation.&n...
Published : 15 Jul 2022
Read MoreWe are glad to announce that Aagami is attending the International Life Sciences Partnering Conference – BIO-Europe® 2022 (October 2...
Published : 11 Jul 2022
Read MoreAagami successfully completed 45+ One-on-One partnering meetings in BIO International Convention 2022 in San Diego (June 13-16).Aagami also represente...
Published : 23 Jun 2022
Read MoreAagami has bagged an assignment to find and establish Partnerships for FDA approved Manufacturing facilities in the US for the controlled substan...
Published : 14 Jun 2022
Read MoreWe have received yet another assignment from a past client who has been giving Aagami periodic assignments after tasting first success with us 5 years...
Published : 16 May 2022
Read More